Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers

Drug Development and Industrial Pharmacy

Volumn 24, Issue 12, 1998, Pages 1113-1128

  Quintanar Guerrero, David ^a,b,c   Allémann, Eric ^b   Fessi, Hatem ^c   Doelker, Eric ^b  

^a Universities of Geneva and Lyon   (France)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c UNIVERSITÉ LYON 1   (France)

Author keywords

Mechanism of formation; Nanocapsules; Nanoparticles; Nanospheres; Preparation methods

Indexed keywords

EXCIPIENT; POLYMER;

ARTICLE; BIODEGRADATION; DIFFUSION; DRUG FORMULATION; EMULSION; EVAPORATION; PHYSICAL CHEMISTRY; TECHNIQUE;

EID: 0345084474     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.3109/03639049809108571     Document Type: Article

References (74)

1. J. Kreuter, in Colloid Drug Delivery Systems (J. Kreuter, ed.), Marcel Dekker, New York, 1994, pp. 219-315.
2. S. J. Douglas, S. S. Davis, and L. Illum, Crit. Rev. Ther. Drug. Carr. Syst., 3, 233-261 (1987).
3. P. Couvreur, Crit. Rev. Ther. Drug. Carr. Syst., 5, 1-20 (1988).
4. P. Couvreur and F. Puisieux, Adv. Drug. Deliv. Rev., 10, 141-162 (1993).
5. B. Magenheim and S. Benita, STP Pharm. Sci., 4, 221-241 (1991).
6. J. A. Bouwstra and H. E. J. Hofland, in Niosomes (J. Kreuter, ed.), Marcel Dekker, New York, 1994, pp. 191-214.
7. M. Grit, J. H. De Smidt, J. H. Struijke, and D. J. A. Crommelin. Int. J. Pharm., 50, 1-6 (1989).
8. E. Allémann, R. Gurny, and E. Doelker, Eur. J. Pharm. Biopharm., 39, 173-191 (1993).
9. P. Couvreur, C. Dubernet, and F. Puisieux, Eur. J. Pharm. Biopharm., 41, 2-13 (1995).
10. M. M. Gallardo, L. Roblot-Treupel, J. Mahuteau, I. Genin, P. Couvreur, P. Plat, and F. Puisieux, Proceedings of the 5th International Conference on Pharmaceutical Technology, APGI, Paris, 1989, pp. 36-45.
11. R. K. Kulkarni, E. G. Moore, A. F. Hegyeli, and F. Leonard, J. Biomed. Mat. Res., 5, 169-181 (1971).
12. J. M. Brady, D. E. Cutright, R. A. Miller, and G. C. Battistone, J. Biomed. Mat. Res., 7, 155-166 (1973).
13. R. A. Miller, J. M. Brady, and D. E. Cutright, J. Biomed. Mat. Res., 11, 711-719 (1977).
14. C. C. Chu, Polymerization, 26, 591-594 (1985).
15. P. P. Speiser, Meth. Find. Exp. Clin. Pharmacol., 13, 337-342 (1991).
16. J. M. Rollot, P. Couvreur, L. Roblot-Treupel, and F. Puisieux, J. Pharm. Sci., 75, 361-364 (1986).
17. G. Puglisi, M. Fresta, G. Giammona, and C. A. Ventura, Int. J. Pharm., 125, 283-287 (1995).
18. N. Al Kouhri Fallouh, L. Roblot-Treupel, H. Fessi, J. P. H. Devissaguet, and F. Puisieux, Int. J. Pharm., 28, 125-132 (1986).
19. H. Fessi, F. Puisieux, and J. P. Devissaguet, Eur. Patent 274 961 (1987).
20. D. Quintanar-Guerrero, H. Fessi, E. Allémann, and E. Doelker, French Patent Appl., 97 09 672 (1997).
21. J. W. Vanderhoff, M. S. El-Aasser, and J. Ugelstad, U.S. Patent 4 177 177 (1979).
22. D. F. Evans and H. Wennerström, in The Colloidal Domain, VCH Publishers, Cambridge, 1994, pp. 482-485.
23. R. Bodmeir and J. W. McGinity, Int. J. Pharm., 43, 179-186 (1988).
24. A. Weissler, J. Acoust. Soc. Am., 25, 651-657 (1953).
25. H. J. Krause, A. Schwarz, and P. Rohdewald, Int. J. Pharm., 27, 145-155 (1985).
26. M. J. Alonso, Drugs Pharm. Sci., 77, 203-242 (1996).
27. R. Bodmeier and H. Chen, J. Control. Rel., 12, 223-233 (1990).
28. E. Mayhew, G. Nikolopoulos and A. Siciliano, Amer. Biotechnol. Lab., 3, 36-41 (1985).
29. E. Mayhew, R. Lazo, W. J. Vail, J. King, and A. M. Green, Biochim. Biophys. Acta, 775, 169-174 (1984).
30. R. Gurny and N. A. Peppas, Drug Dev. Ind. Pharm., 7, 1-25 (1981).
31. M. C. Julienne, F. Foussard, and J. P. Benoit, Proc. Intern. Symp. Control. Rel. Bioact. Mater., 16, 77-78 (1989).
32. M. D. Coffin and J. W. McGinity, Pharm. Res., 9, 200-205 (1992).
33. T. Verrecchia, P. Huve, D. Bazile, M. Veillard, G. Spenlehauer, and P. Couvreur, J. Biomed. Mater. Res., 27, 1019-1028 (1993).
34. A. Sanchez, J. L. Vila-Jato, and M. J. Alonso, Int. J. Pharm., 99, 263-273 (1993).
35. R. H. Müller and K. H. Wallis, Int. J. Pharm., 89, 25-31 (1993).
36. P. D. Scholes, A. G. A. Coombes, L. Illum, S. S. Davis, M. Vert, and M. C. Davies, J. Control. Rel., 25, 145-153 (1993).
37. S. E. Frisbee and J. McGinity, Eur. J. Pharm. Biopharm., 40, 355-363 (1994).
38. G. F. Dawson and G. W. Halbert, J. Pharm. Pharmacol., 46, 1037 (1994).
39. T. Verrechia, G. Spenlehauer, D. V. Bazile, A. Murry-Brelier, Y. Archimbaud, and M. Veillard, J. Control. Rel., 36, 49-61 (1995).
40. F. B. Landry, D. V. Bazile, G. Spenlehauer, M. Veillard, and J. Kreuter, Biomaterials, 17, 715-723 (1996).
41. M. Ueda and J. Kreuter, J. Microencapsulation, 14, 593-605 (1997).
42. F. B. Landry, D. V. Bazile, G. Spenlehauer, M. Veillard and J. Kreuter, J. Control. Rel., 44, 227-236 (1997).
43. International Conference on Harmonization guidelines residual solvents, 62 Federal Register 67377-67388 (November 7, 1996).
44. D. Quintanar-Guerrero, A. Ganem-Quintanar, E. Allémann, H. Fessi, and E. Doelker, J. Microencapsulation, 15, 107-119 (1998).
45. T. Yamaoka, Y. Tabata, and Y. Ikada, J. Pharm. Pharmacol., 47, 479-486 (1995).
46. M. C. Julienne, M. J. Alonso, J. L. Amoza, and J. P. Benoit, Drug. Dev. Ind. Pharm., 18, 1063-1077 (1992).
47. R. Jalil and J. R. Nixon, J. Microencapsulation, 7, 297-325 (1990).
48. M. D. Blanco and M. J. Alonso, Eur. J. Pharm. Biopharm., 43, 287-294 (1997).
49. H. Fessi, F. Puisieux, J. P. Devissaguet, N. Ammoury, and S. Benita, Int. J. Pharm., 55, R1-R4 (1989).
50. D. Quintanar-Guerrero, E. Allémann, E. Doelker, and H. Fessi, Colloid. Polym. Sci., 275, 640-647 (1997).
51. J. T. Davies and E. K. Rideal, Interfacial Phenomena, Academic Press, New York, 1961, pp. 319-326, 359-366.
52. J. Molpeceres, M. Guzman, M. R. Aberturas, M. Chacon, and L. Berges, J. Pharm. Sci., 85, 206-213 (1996).
53. S. Stainmesse, A.-M. Orecchioni, E. Nakache, F. Puisieux, and H. Fessi, Colloid Polym. Sci., 273, 505-511 (1995).
54. B. Dimitrova, I. B. Ivanov, and E. Nakache, Disp. Sci. Tech., 9, 321-341 (1988).
55. M. Guzman, J. Molpeceres, F. Garcia, M. R. Aberturas, and M. Rodriguez, J. Pharm. Sci., 82, 498-502 (1993).
56. T. Niwa, H. Takeuchi, T. Hino, N. Kunou, and Y. Kawashima, J. Control. Rel., 25, 89-98 (1993).
57. S. Stolnik, M. C. Garnett, M. C. davies, L. Illum, M. Bousta, M. Vert, and S. S. Davis, Colloid Surface A, 97, 235-245 (1995).
58. P. Wehrle, B. Magenheim, and S. Benita, Eur. J. Pharm. Biopharm., 41, 19-26 (1995).
59. J. Kristl, E. Allémann, and R. Gurny, Acta Pharm., 46, 1-12 (1996).
60. S. E. Dunn, A. G. A. Coombes, M. C. Garnett, S. S. Davis, M. C. Davies, and L. Illum, J. Control. Rel., 44, 65-76 (1997).
61. H. Murakami, Y. Kawashime, T. Niwa, T. Hino, H. Takeuchi, and M. Kobayashi, Int. J. Pharm., 149, 43-49 (1997).
62. T. Niwa, H. Takeuchi, T. Hino, N. Kunou, and Y. Kawashima, J. Pharm. Sci., 83, 727-732 (1994).
63. S. S. Guterres, H. Fessi, G. Barrat, J.-P. Devissaguet, and F. Puisieux, Int. J. Pharm., 113, 57-63 (1995).
64. N. S. Santos-Magalhaes, H. Fessi, F. Puisieux, S. Benita, and M. Sheiller, J. Microencapsulation, 12, 195-205 (1995).
65. C. Bindschaedler, R. Gurny, and E. Doelker, U.S. Patent, 4 968 350 (1990).
66. E. Allémann, Ph.D. thesis, No. 2619, University of Geneva, 1989.
67. J. C. Leroux, Ph.D. thesis, No. 2785, University of Geneva, 1996.
68. C. E. Matkovich, Anal. Chem., 45, 1915-1921 (1973).
69. H. Ibrahim, Ph.D. thesis, No. 2369, University of Geneva, 1989.
70. E. Allémann, R. Gurny, and E. Doelker, Int. J. Pharm., 87, 247-253 (1992).
71. E. Allémann, J.-C. Leroux, R. Gurny, and E. Doelker, Pharm. Res., 10, 1732-1737 (1993).
72. J. C. Leroux, R. Cozens, J. L. Roesel, B. Galli, F. Kubel, E. Doelker, and R. Gurny, J. Pharm. Sci., 84, 1387-1391 (1995).
73. D. Quintanar-Guerrero, E. Allémann, H. Fessi, and E. Doelker, Pharm. Res., 14, 119-127 (1997).
74. J. C. Leroux, E. Allémann, E. Doelker, and R. Gurny, Eur. J. Pharm. Biopharm., 41, 14-18 (1995).